Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications.

Brandt, Christian; Sánchez-Álvarez, Juan Carlos; Steinhoff, Bernhard J; Milanov, Ivan; Serratosa, Jose M

Brandt, Christian; Sánchez-Álvarez, Juan Carlos; Steinhoff, Bernhard J; Milanov, Ivan; Serratosa, Jose M.

Afiliação

Brandt C; Department of General Epileptology, Bethel Epilepsy Centre, Mara Hospital, Maraweg 21, 33617 Bielefeld, Germany. Electronic address: christian.brandt@mara.de.
Sánchez-Álvarez JC; Neurology Service, Epilepsy Unit, Hospital Vithas la Salud, Granada, Spain.
Steinhoff BJ; Department for Adults, Kork Epilepsy Center, Landstrasse 1, 77694 Kehl-Kork, Germany; Clinic for Neurology and Neurophysiology, Breisacher Str. 64, 79106 Freiburg, Germany. Electronic address: bsteinhoff@epilepsiezentrum.de.
Milanov I; Neurology Clinic, Medical University of Sofia, 15 Blvd. Acad. Ivan Evstr. Geshov, 1431 Sofia, Bulgaria.
Serratosa JM; Epilepsy Unit, Department of Neurology, IIS Fundación Jiménez Díaz, Avenida Reyes Católicos, 28040 Madrid, Spain. Electronic address: joseserratosa@me.com.

Seizure ; 96: 86-93, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35168142

Assuntos

Anticonvulsivantes; Clorofenóis; Anticonvulsivantes/efeitos adversos; Carbamatos/efeitos adversos; Clorofenóis/efeitos adversos; Método Duplo-Cego; Quimioterapia Combinada; Humanos; Tetrazóis; Resultado do Tratamento

Palavras-chave

Epilepsy; Focal seizures; Responder rates; Seizure-free

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clorofenóis / Anticonvulsivantes Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Seizure Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google